Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms 11C-PBR-28, PBR-28 |
Target |
Mechanism TSPO inhibitors(Translocator protein inhibitors), PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC21H20N2O3 |
InChIKeyDHZBNHMEIOBPAE-JVVVGQRLSA-N |
CAS Registry1005325-43-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Parkinson Disease | Phase 2 | SE | 01 Apr 2012 | |
Diagnostic agents | Phase 2 | - | - | |
Multiple Sclerosis | Phase 1 | GB | 01 Oct 2015 |
Phase 1/2 | 52 | (Baseline Brain PET in Acute TBI Patient) | jguoykbpku(evjuwdxegj) = kdhipdhmoz bqvpsmqxzd (atwzpucudw, eyzsjqyumt - boltltkldx) View more | - | 30 Jul 2021 | ||
(Repeat Brain PET in Acute TBI Patient) | jguoykbpku(evjuwdxegj) = dpemonsdfa bqvpsmqxzd (atwzpucudw, nzohozsbhw - uehgzssbzw) View more | ||||||
Not Applicable | Alzheimer Disease 18 kDa translocator protein (TSPO) | - | 11C-PBR28 | vvigbxpetg(ddwccjuxex) = ylxetudbhg brpubkkgac (krviqlgymv ) | - | 01 Aug 2016 | |
11C-PBR28 | vvigbxpetg(ddwccjuxex) = aumopthkdf brpubkkgac (krviqlgymv ) |